BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15/12/2010

FDA Releases Draft Guidance on Codevelopment of Unmarketed Investigational Drugs for Combination Therapy

The FDA has made available a draft guidance to help industry sponsors develop novel, unmarketed investigational drugs in combination to treat diseases, addressing scientific and regulatory issues that arise during this process

Source: Federal Register — Health and Human ServicesOpen original release →